Brain+ AS (OCSE:BRAINP) ROCE % : -41.05% (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Brain+ AS's annualized ROCE % for the quarter that ended in Jun. 2024 was -41.05%.

Brain+ AS ROCE % Historical Data

The historical data trend for Brain+ AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS ROCE % Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-26.80

-25.43

-29.99

-27.29

-50.00

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROCE %	Get a 7-Day Free Trial				-36.53	-40.52	-32.21	-58.15	-41.05

Brain+ AS ROCE % Calculation

Brain+ AS's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-17.487	/	( ( (45.372 - 7.091)	+	(35.97 - 4.3) )	/ 2 )
	=	-17.487	/	( (38.281	+	31.67)	/ 2 )
	=	-17.487	/	34.9755
	=	-50.00 %

Brain+ AS's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Dec. 2023 )		(Q: Jun. 2024 )
	=	-13.344	/	( ( (35.97 - 4.3)	+	(37.859 - 4.512) )	/ 2 )
	=	-13.344	/	( ( 31.67	+	33.347 )	/ 2 )
	=	-13.344	/	32.5085
	=	-41.05 %

(1) Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

Brain+ AS (OCSE:BRAINP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Brain+ AS ROCE % Related Terms

Thank you for viewing the detailed overview of Brain+ AS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Brain+ AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kobmagergade 53, 3rd Floor, Copenhagen, DNK, 1150

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS Headlines

No Headlines